Text and Data Mining valid from 2019-03-12
Received: 23 July 2018
Accepted: 27 February 2019
First Online: 12 March 2019
Ethics approval and consent to participate
: The present data pooling has been approved by the Ethics Committee of the Charité – Universitätsmedizin Berlin, Germany (EA4/087/08). Furthermore, each individual study was approved by the local Ethics Committee before (Ethics Committee Witten/Herdecke, Germany (114/2016); Ethics Committee of the Elisabethinen University Teaching Hospital Linz, Austria (K-103-16)). All study patients gave written informed consent.
: Not applicable.
: JH, JS, MM, RH, AS, PK, HP and MW have nothing to declare. JBF has received consulting, lecture, and advisory board fees from BioClinica, Cerevast, Artemida, Brainomix, and Lundbeck. PUH reports research grants from Charité–Universitätsmedizin Berlin (within MonDAFIS, supported by an unrestricted research grant to the Charité from Bayer), University Göttingen (within FIND-AFrandomized, supported by an unrestricted research grant to the University Göttingen from Boehringer-Ingelheim), and University Hospital Heidelberg (within RASUNOA-prime, supported by an unrestricted research grant to the University Hospital Heidelberg from Bayer HealthCare, BMS, Boehringer-Ingelheim, Daiichi Sankyo), outside submitted work. KGH received lecture honoraria from Bayer HealthCare, Sanofi-Aventis, Pfizer, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi Sankyo, Biotronik, W. L. Gore & Associates; honoraria for consulting from Edwards Lifesciences, Bayer HealthCare, Pfizer, Daiichi Sankyo, Boehringer Ingelheim, EIP Pharma and Medtronic as well as research grants from Bayer HealthCare and Sanofi-Aventis.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.